Company: BIAF
Filing Date: 2025-06-02
Form Type: DEF 14A
Source: 0001641172-25-013280
Chunk: 34

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-06-02
Form: DEF 14A
Chunk 34
---
 subject to the periodic reporting and other requirements of the Exchange Act. The
Reverse Stock Split will not affect the registration of the Common Stock under the Exchange Act or the listing of the Common Stock on
Nasdaq Capital Market (other than to the extent it facilitates compliance with Nasdaq Capital Market continued listing standards). Following
the Reverse Stock Split, the Common Stock will continue to be listed on the Nasdaq Capital Market, although it will be considered a new
listing with a new Committee on Uniform Securities Identification Procedures (“CUSIP”) number.

The rights of the holders of the Common Stock will
not be affected by the Reverse Stock Split, other than as a result of the treatment of fractional shares as described below. For example,
a holder of 2% of the voting power of the outstanding shares of the Common Stock immediately prior to the effectiveness of the Reverse
Stock Split will generally continue to hold 2% of the voting power of the outstanding shares of the Common Stock immediately after effecting
the Reverse Stock Split. The number of stockholders of record will not be affected by the Reverse Stock Split (except to the extent any
are cashed out as a result of holding fractional shares). If approved and implemented, the Reverse Stock Split may result in some stockholders
owning “odd lots” of less than 100 shares of the Common Stock. Odd lot shares may be more difficult to sell, and brokerage
commissions and other costs of transactions in odd lots are generally higher than the costs of transactions in “round lots”
of even multiples of 100 shares. The Board believes, however, that these potential effects are outweighed by the benefits of the Reverse
Stock Split.

Effectiveness of the Reverse Stock Split.The
Reverse Stock Split, if approved by our stockholders, would become effective upon the filing and effectiveness (the “Effective Time”) of an amendment to our Certificate of Incorporation with the Secretary of State of the State of Delaware, which would
take place at the Board’s discretion. The exact timing of the filing of the Reverse Stock Split Amendment, if filed, would be determined
by the Board based on its evaluation as to when such action would be the most advantageous to us and our stockholders. In addition, the
Board reserves the right, notwithstanding stockholder approval and without further action by the stockholders, to elect not to proceed
with the Reverse Stock Split at any time prior to filing the Reverse Stock Split Amendment with the Secretary of State of the State of
Delaware, if the Board,